The Valley Desk

ReviewJournal of the American Academy of DermatologyPublished

Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Journal of the American Academy of Dermatology
Published
Subject terms
Humans; Psoriasis; Interleukin-17; Interleukin-23; Latent Tuberculosis; Tuberculosis; Safety; Biologics; Il-17 Inhibitors; Il-23 Inhibitors
PubMed ID
41260526
Added to directory
Source checked

Report a correction or request removal